{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:35:33Z","timestamp":1790919333735,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009716","name":"Osteoporosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bone.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T16:35:26Z","timestamp":1530981326000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: A registry-based cohort study"],"prefix":"10.1016","volume":"114","author":[{"given":"William D.","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ego","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-492X","authenticated-orcid":false,"given":"Suzanne N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit R.","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.07.004_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2018.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: scientific review","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2018.07.004_bb0015","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2018.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0025","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00198-017-4009-0","article-title":"Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting","volume":"28","author":"Kanis","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0030","author":"Kanis"},{"key":"10.1016\/j.bone.2018.07.004_bb0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","article-title":"BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures","volume":"18","author":"Stone","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0040","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density thresholds for pharmacological intervention to prevent fractures","volume":"164","author":"Siris","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2018.07.004_bb0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1503\/cmaj.070234","article-title":"Low bone mineral density and fracture burden in postmenopausal women","volume":"177","author":"Cranney","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.bone.2018.07.004_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","article-title":"A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation","volume":"11","author":"Kanis","year":"2016","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2018.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.bone.2018.07.004_bb0060","first-page":"JS10","article-title":"Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system","volume":"37","author":"Roos","year":"1999","journal-title":"Med. Care"},{"key":"10.1016\/j.bone.2018.07.004_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/JCD:6:3:275","article-title":"Establishing a regional bone density program: lessons from the Manitoba experience","volume":"6","author":"Leslie","year":"2003","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2018.07.004_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/JCD:8:1:025","article-title":"Construction and validation of a population-based bone densitometry database","volume":"8","author":"Leslie","year":"2005","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2018.07.004_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1471-2458-12-301","article-title":"Osteoporosis-related fracture case definitions for population-based administrative data","volume":"12","author":"Lix","year":"2012","journal-title":"BMC Public Health"},{"issue":"143","key":"10.1016\/j.bone.2018.07.004_bb0080","article-title":"Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study","volume":"8","author":"O'Donnell","year":"2013","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2018.07.004_bb0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","article-title":"Construction of a FRAX((R)) model for the assessment of fracture probability in Canada and implications for treatment","volume":"22","author":"Leslie","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","article-title":"Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos","volume":"22","author":"Fraser","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0095","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jbmr.123","article-title":"Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration","volume":"25","author":"Leslie","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2888","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","author":"Khosla","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1359\/jbmr.081116","article-title":"Bridging the osteoporosis quality chasm","volume":"24","author":"Curtis","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0110","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-016-3894-y","article-title":"Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures","volume":"28","author":"Harvey","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-5908-5-80","article-title":"A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis","volume":"5","author":"Little","year":"2010","journal-title":"Implement. Sci."},{"key":"10.1016\/j.bone.2018.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4065\/80.3.343","article-title":"Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to \u22122.5 at the femoral neck: the fracture intervention trial","volume":"80","author":"Quandt","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bone.2018.07.004_bb0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1359\/jbmr.071105","article-title":"Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia","volume":"23","author":"Seeman","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.07.004_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S8756-3282(03)00200-X","article-title":"Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of raloxifene evaluation trial","volume":"33","author":"Kanis","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.07.004_bb0145","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2018.07.004_bb0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00198-004-1698-y","article-title":"Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos. Int."},{"issue":"10122","key":"10.1016\/j.bone.2018.07.004_bb0155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2018.07.004_bb0160","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized risk-stratified osteoporosis strategy evaluation (ROSE) study","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","article-title":"Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks","volume":"19","author":"Nguyen","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-006-0306-8","article-title":"Enhanced prediction of fracture risk combining vertebral fracture status and BMD","volume":"18","author":"Siris","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0175","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.bone.2018.07.004_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13697137.2015.1092342","article-title":"Fracture prediction without bone mineral density","volume":"18","author":"Kanis","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.bone.2018.07.004_bb0185","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.07.004_bb0190","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00198-016-3865-3","article-title":"The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA","volume":"28","author":"Wright","year":"2017","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:40:23Z","timestamp":1762659623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218302618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"alternative-id":["S8756328218302618"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.07.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: A registry-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}